Bionik Laboratories Corp.
BNKL
$0.0001
$0.000.00%
BNKL market cap represents
0.00%
of the industry.
Valuation
BNKL
Low
BNKL
Industry Average
High
Market Cap
1.26K
< 1.25K
> 20.77B
Enterprise Value
--
-303.52M
546.68B
Price/Earnings (TTM)
0.00
< -10.00
> 50.00
Earnings Per Share Growth (TTM)
-59.53%
< -60.00%
> 150.00%
Price/Earnings To Growth (TTM)
--
0.01
9.63
Price/Sales (TTM)
0.00
< 0.000
> 30.00
Price/Book (Q)
0.00
< -10.00
> 10.00
Enterprise Value/Revenue (TTM)
--
-19.37
535.77
Enterprise Value/EBITDA (TTM)
--
-5,443.64
219.57
Enterprise Value/EBIT (TTM)
--
-1,425.77
300.42
Dividends and Shares
BNKL
Low
BNKL
Industry Average
High
Shares Outstanding
6.98M
105.80K
> 240.00M
Dividend Per Share (Most Recent)
--
0.03
2.10
Dividend Per Share (TTM)
--
0.03
8.40
Dividend Yield (TTM)
--
0.19%
7.75%
Payout Ratio (TTM)
--
-1,820.24
926.87
Price History
BNKL
Low
BNKL
Industry Average
High
Beta
-37.31
< -40.00
3.76
1-Month Total Return
0.00%
< -20.00%
> 0.00%
3-Month Total Return
9,900.00%
< -30.00%
328.03%
6-Month Total Return
9,900.00%
< 0.00%
604.55%
Year to Date Total Return
9,900.00%
< -20.00%
360.12%
1-Year Total Return
9,900.00%
< 0.00%
701.00%
2-Year Total Return
-99.98%
-99.99%
> 30.00%
3-Year Total Return
-99.97%
-99.98%
> 0.00%
5-Year Total Return
-99.99%
-100.00%
> 340.00%
Profitability
BNKL
Low
BNKL
Industry Average
High
Operating Margin (TTM)
-264.40%
< -1,280.00%
> -260.00%
Profit Margin (TTM)
-273.98%
< -1,120.00%
> -270.00%
Management Effectiveness
BNKL
Low
BNKL
Industry Average
High
Return on Assets (TTM)
-74.23%
< -80.00%
> 0.00%
Return on Equity (TTM)
--
0.36%
824.40%
Income Statement
BNKL
Low
BNKL
Industry Average
High
Revenue (TTM)
1.81M
< 0.00
> 24.63B
Total Revenue (TTM)
1.81M
< 0.00
> 25.21B
Total Revenue Growth (Q YOY)
161.94%
< 160.00%
> 1,220.00%
Revenue Per Share (TTM)
0.26
< 0.00
> 130.00
Gross Profit (TTM)
989.90K
< 0.00
> 4.87B
EBITDA (TTM)
-4.71M
< -10.00M
> 1.73B
EBIT (TTM)
-4.77M
< -10.00M
> 1.28B
Net Income (TTM)
-4.95M
< -10.00M
> 680.00M
Net Income Avl. to Common (TTM)
-4.95M
< -10.00M
> 680.00M
Earnings Growth (Q YOY)
20.46%
< -400.00%
> 30.00%
EPS Diluted (TTM)
-0.72
< -10.00
> 0.00
EPS Diluted Growth (Q YOY)
33.26%
< -90.00%
> 40.00%
Balance Sheet
BNKL
Low
BNKL
Industry Average
High
Cash and Short-Term Inv. (Q)
427.40K
45.00K
> 1.85B
Cash Per Share (Q)
0.06
0.01
> 20.00
Total Current Assets (Q)
2.78M
18.60K
> 6.12B
Total Assets (Q)
3.36M
941.70K
> 17.19B
Total Current Liabilities (Q)
2.31M
110.30K
> 5.34B
Total Debt (Q)
2.41M
0.00
> 5.20B
Total Liabilities (Q)
5.00M
272.00K
> 11.22B
Total Common Equity (Q)
-1.64M
< -10.00M
> 5.71B
Total Preferred Equity (Q)
--
0.00
920.42M
Total Equity (Q)
-1.64M
< -10.00M
> 5.96B
Current Ratio (Q)
1.203
0.111
> 10.000
Book Value Per Share (Q)
-0.23
< -10.00
> 20.00
Cash Flow
BNKL
Low
BNKL
Industry Average
High
Cash from Operations (TTM)
-3.39M
< -10.00M
> 1.12B
Cash from Investing (TTM)
-223.80K
< -760.00M
> 0.00
Cash from Financing (TTM)
2.05M
< -350.00M
> 10.00M
Net Change in Cash (TTM)
-1.56M
< -10.00M
> 30.00M
Levered Free Cash Flow (TTM)
-1.58M
< -10.00M
> 660.00M
TTM - Trailing twelve months. Q - Most recent quarter. YOY - Year over year.
The comparison requires a security to have a minimum 30 day average trading volume of 100,000 at $1 or over, or a $5 minimum price.
* Lowest and highest value for any one individual security in the industry.
The comparison requires a security to have a minimum 30 day average trading volume of 100,000 at $1 or over, or a $5 minimum price.
* Lowest and highest value for any one individual security in the industry.
